Skip to main content
Clinical Trials/NL-OMON23738
NL-OMON23738CompletedNot Applicable

Management of Atrial fibriLLation INcluding tailoring of anticoagulation in patients from primary care

Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.0 sites1,000 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,000

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Participating primary care practices need to be willing and able to provide integral management to their AF patients.
  • Patients aged 65 years or over of participating practices with documented AF are eligible for participation if they do not meet any of the exclusion criteria.

Exclusion Criteria

  • Unwillingness to provide informed consent by the participating general practitioners is the only exclusion criterion for primary care practices in this study.
  • Patients are not eligible for this study if
  • a) they have a life expectancy shorter than 3 months,

Investigators

Sponsor
Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.

Similar Trials